Cittadine Andrew 4
4 · Monopar Therapeutics · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Cittadine Andrew
Chief Operating Officer
Transactions
- Award
Stock Options
2025-12-02+8,969→ 8,969 totalExercise: $75.94Exp: 2035-12-02→ Common Stock (8,969 underlying) - Award
Restricted Stock Units
2025-12-02+13,919→ 52,593 totalExercise: $0.00→ Common Stock (13,919 underlying)
Footnotes (2)
- [F1]Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
- [F2]RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.